Litcius/Paper detail

Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trial

Jung‐Min Ahn, Do‐Yoon Kang, Pil Hyung Lee, Youngkeun Ahn, Won‐Jang Kim, Chang‐Wook Nam, Jin‐Ok Jeong, In‐Ho Chae, Hiroki Shiomi, Paul Hsien Li Kao, Joo‐Yong Hahn, Sung‐Ho Her, Bong‐Ki Lee, Tae Hoon Ahn, Kiyuk Chang, Jei Keon Chae, David Smyth, Gregg W. Stone, Duk‐Woo Park, Seung‐Jung Park, Seung‐Jung Park

2023American Heart Journal29 citationsDOI

Topics & Concepts

MedicinePercutaneous coronary interventionRandomized controlled trialConventional PCICardiologyInternal medicineFractional flow reserveClinical endpointVulnerable plaqueRevascularizationMyocardial infarctionStenosisTarget lesionCoronary angiographyCoronary Interventions and DiagnosticsCerebrovascular and Carotid Artery DiseasesCardiac Imaging and Diagnostics
Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trial | Litcius